The First Affiliated Hospital with Nanjing Medical University: Stomach Neoplasms trials
The registry lists 26 Stomach Neoplasms studies with The First Affiliated Hospital with Nanjing Medical University as lead sponsor. 18 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 15Phase 3 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant TherapyNot yet recruitingNCT07669740Phase 2
- Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOXNot yet recruitingNCT07391826Phase 2
- Robotic vs Laparoscopic Gastrectomy for cT4a Gastric CancerNot yet recruitingNCT07331454Phase 3
- QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric CancerNot yet recruitingNCT07315035Phase 2
- Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ AdenocarcinomaRecruitingNCT07277439Phase 2
- AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CTRecruitingNCT07250347
- Feasibility and Safety of Laparoscopic Purse-string Suture Clamp and Multi-functional Seal Cap for Totally Laparoscopic Radical Total GastrectomyNot yet recruitingNCT07117812Not applicable
- Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion ImmunochemotherapyRecruitingNCT07056010Not applicable
- Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II TrialNot yet recruitingNCT07050524Phase 2
- Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant TherapyRecruitingNCT06895447Phase 2
- A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver MetastasisNot yet recruitingNCT06564298Phase 2
- A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric CancerRecruitingNCT06555471Phase 2
- RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric CancerNot yet recruitingNCT06385873Phase 2
- Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALMRecruitingNCT06341595Phase 2
- A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.Not yet recruitingNCT05594381Phase 2
- Multi-parametric MRI and Dual-energy CT in Patients of Gastric CancerRecruitingNCT05508126
- XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction AdenocarcinomaRecruitingNCT05494060Phase 2
- The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical GastrectomyNot yet recruitingNCT05356156Not applicable
- Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic GastrectomyCompletedNCT07351474Not applicable
- Using ctDNA to Guide Treatment Decisions for Stage III Gastric CancerActive, not recruitingNCT06939439Phase 3
- MRI and CT in Gastroesophageal Junction or Upper Gastric AdenocarcinomaActive, not recruitingNCT06640153
- The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PMActive, not recruitingNCT06427252Phase 2
- Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT)CompletedNCT04963088Phase 1/2
- Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid BiopsyStatus unknownNCT04385316
- The Safety of Totally Laparoscopic Versus Laparoscopy-Assisted Total Gastrectomy.Status unknownNCT04351321Not applicable
- Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer PatientsStatus unknownNCT02644148Phase 2